L'intérêt à découvert pour bioAffinity Technologies donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de bioAffinity Technologies. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

bioAffinity Technologies (NASDAQ:BIAF) Stock, Rapport sur les intérêts à découvert

bioAffinity Technologies

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies Inc

Rosenblatt analyst Barton Crockett reiterated the Buy rating on Stagwell Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STGW#NASDAQ">STGW</a>) on Thursday,<a target="_blank" href="https://www.benzinga.com/quote/STGW/analyst-ratings" rel="noreferrer noopener"> with a price forecast of $10.</a>
The analyst writes that Stagwell doesn&#8217;t need to experience double-digit growth or significant margin expansion to justify a higher valuation compared to its peers.
Even if it grows at a more modest mid-single-digit pace with stable margins, Stagwell should still command a strong EV/EBITDA multiple. However, the company is currently trading at 6.7x 2025E EBITDA, slightly below the peer average of 6.9x and the historical outperformer Publicis, which is valued at 7.3x.
Per Crockett, if Stagwell were able to meet its growth projections, the analyst suggests that its multiple could rise, supporting a price forecast of $10 per share.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/technicals/25/04/44629335/apple-stock-slammed-by-trump-tariffs-is-a-death-cross-next" rel="noreferrer noopener">Apple Stock Slammed By Trump Tariffs: Is A Death Cross Next?</a>
Despite being down 9% year-to-date, which is better than the peer group&#8217;s 15% decline, Stagwell&#8217;s stock could perform better if it achieves its 12% five-year compound annual growth rate and 500+ basis points in margin expansion, the analyst writes.
Meanwhile, there is skepticism in the market due to broader macroeconomic concerns, and there is a risk that Stagwell could miss its targets, which would negatively affect its stock performance, even if the company continues to grow faster than its peers.
Crockett has updated the firm&#8217;s financial model to better align with Stagwell&#8217;s long-term goals.
While the quarterly cadence for 2025 has shifted, with less growth expected in the first quarter and more in the fourth, the overall revenue forecast for the year remains largely unchanged.
Previously, the analyst had projected Stagwell would achieve double-digit revenue growth mainly through acquisitions rather than organic growth, but now Crockett adjusted the expectations to focus more on Stagwell&#8217;s revenue ambitions.
Additionally, the analyst had assumed steady margins in the past, but given the company&#8217;s recent guidance on AI-driven cost savings, the analyst now sees margin expansion in the near term.
Price Action: STGW is down 6.31% at $5.648 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44629640/us-services-sector-slows-sharply-as-hiring-drops-tariff-pressures-mount" target="_blank" rel="noreferrer noopener">US Services Sector Slows Sharply As Hiring Drops, Tariff Pressures Mount</a></li>
</ul>
Photo: Jirapong Manustrong/Shutterstock

Analyst Color

Equities

News

Price Target

Reiteration

Markets

Analyst Ratings

Trading Ideas

General

STGW

Stagwell Stock Could Outperform With 12% Growth, But Analyst Warns Of Market Skepticism Amid Macro Concerns

Investors with a lot of money to spend have taken a bullish stance on PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PEP, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for PepsiCo.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 30%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $109,200, and 9, calls, for a total amount of $430,560.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $180.0 for PepsiCo over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of PepsiCo stands at 1545.33, with a total volume reaching 1,518.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in PepsiCo, situated within the strike price corridor from $90.0 to $180.0, throughout the last 30 days.
<h3>PepsiCo 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743704092_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PEP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$18.3</td>
<td>$18.2</td>
<td>$18.2</td>
<td>$170.00</td>
<td>$109.2K</td>
<td>563</td>
<td align="right">70</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.05</td>
<td>$4.5</td>
<td>$4.56</td>
<td>$170.00</td>
<td>$100.3K</td>
<td>4.2K</td>
<td align="right">225</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$65.1</td>
<td>$63.0</td>
<td>$64.0</td>
<td>$90.00</td>
<td>$64.0K</td>
<td>0</td>
<td align="right">0</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/04/25</td>
<td>$5.0</td>
<td>$0.4</td>
<td>$0.89</td>
<td>$152.50</td>
<td>$52.4K</td>
<td>1.1K</td>
<td align="right">589</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.45</td>
<td>$3.25</td>
<td>$3.25</td>
<td>$175.00</td>
<td>$50.3K</td>
<td>831</td>
<td align="right">157</td>
</tr>
</tbody>
</table>

<h3>About PepsiCo</h3>
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US and overseas. International markets made up 40% of both total sales and operating profits in 2024.
<h3>Where Is PepsiCo Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 4,339,444, the PEP's price is up by 1.77%, now at $151.76. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 21 days.</li>
</ul>
<h3>What Analysts Are Saying About PepsiCo</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $164.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Jefferies downgraded its action to Hold with a price target of $170. 
&#x2A; An analyst from Barclays has revised its rating downward to Equal-Weight, adjusting the price target to $156. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for PepsiCo, targeting a price of $168. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PepsiCo with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

PepsiCo Unusual Options Activity For April 03

Investors with a lot of money to spend have taken a bullish stance on AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AZO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 8 uncommon options trades for AutoZone.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $212,260, and 4 are calls, for a total amount of $224,700.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $3100.0 and $4250.0 for AutoZone, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for AutoZone's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AutoZone's whale activity within a strike price range from $3100.0 to $4250.0 in the last 30 days. 
<h3>AutoZone Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743704086_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AZO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$91.0</td>
<td>$89.0</td>
<td>$91.0</td>
<td>$3400.00</td>
<td>$81.9K</td>
<td align="right">28</td>
<td align="right">9</td>
</tr>
<tr>
<td>AZO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$696.0</td>
<td>$676.0</td>
<td>$696.0</td>
<td>$3100.00</td>
<td>$69.6K</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>AZO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$604.0</td>
<td>$588.0</td>
<td>$588.0</td>
<td>$3310.00</td>
<td>$58.8K</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>AZO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$584.0</td>
<td>$572.0</td>
<td>$584.0</td>
<td>$3200.00</td>
<td>$58.4K</td>
<td align="right">10</td>
<td align="right">1</td>
</tr>
<tr>
<td>AZO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$57.5</td>
<td>$43.8</td>
<td>$50.0</td>
<td>$3800.00</td>
<td>$45.0K</td>
<td align="right">42</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About AutoZone</h3>
AutoZone operates as a leading retailer of aftermarket automotive parts in the United States. The firm operates more than 6,400 stores domestically, serving both the do-it-yourself and commercial (do-it-for-me) end markets. Through its vast store footprint and distribution network, AutoZone manages a wide array of stock-keeping units applicable to numerous vehicle makes and models, providing its consumers with ample product availability. The firm drives traffic by providing superior and convenient customer service as AutoZone's team of knowledgeable staff assists consumers with diagnosing a vehicle's problem, selecting the necessary part for replacement, and occasionally, installation. The company also operates internationally, with 800 stores in Mexico and more than 100 in Brazil.
<h3>AutoZone's Current Market Status</h3>
<ul>
<li>With a trading volume of 92,316, the price of AZO is up by 0.98%, reaching $3846.7.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 47 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for AutoZone</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $3863.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Roth MKM has decided to maintain their Buy rating on AutoZone, which currently sits at a price target of $3763. 
&#x2A; An analyst from B of A Securities persists with their Neutral rating on AutoZone, maintaining a target price of $3700. 
&#x2A; An analyst from DA Davidson upgraded its action to Buy with a price target of $4192. 
&#x2A; Maintaining their stance, an analyst from BMO Capital continues to hold a Outperform rating for AutoZone, targeting a price of $3850. 
&#x2A; An analyst from Goldman Sachs has elevated its stance to Neutral, setting a new price target at $3811. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AutoZone, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

This Is What Whales Are Betting On AutoZone

The <a href="https://www.benzinga.com/topic/cannabis-products">cannabis accessories industry</a> is experiencing explosive global growth. As legalization spreads across North America, Europe and beyond, demand for high-quality pre-rolls, rolling papers and smoking gear is surging. But only companies that master large-scale manufacturing, supply chain efficiency and global market differentiation will dominate.
Few businesses exemplify this shift better than Hemper and Hara Supply, two rapidly expanding enterprises meeting skyrocketing global demand. Co-founded by Bryan Gerber, Ravjot &#8220;RJ&#8221; Bhasin, Henry Kochhar and Thai Tran, Hemper focuses on consumer smoking accessories, while Hara Supply specializes in manufacturing pre-roll cones and packaging solutions for cannabis brands worldwide.
&#8220;We started the company together about ten years ago,&#8221; says Gerber, CEO of both Hemper and Hara Supply. &#8220;RJ handles manufacturing in India—most of his tasks involve that, along with international expansion.&#8221;
By balancing branding, supply chain efficiency and international expansion, Hemper and Hara Supply have positioned themselves at the center of the fast-growing pre-rolled cone segment—<a href="https://www.industryresearch.biz/global-pre-rolled-cone-and-conical-tips-market-24226195">valued</a> at $524.18 million in 2022 and expected to reach $12.55 billion by 2028, with a 69.78% CAGR.
Also Read: <a href="https://www.benzinga.com/markets/cannabis/25/04/42205205/gary-payton-wants-you-to-rethink-cannabis-its-about-mental-health-it-brought-my-mom-back-in-her-">Gary Payton Wants You To Rethink Cannabis: &#8216;It&#8217;s About Mental Health… It Brought My Mom Back In Her Final Days&#8217;</a>
<h2 class="wp-block-heading">From Subscription Boxes To Industry Dominance</h2>
Hemper started as a subscription box service, but quickly outgrew its niche. It evolved into a multichannel operation spanning direct-to-consumer sales, wholesale distribution and large-scale manufacturing through Hara Supply.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03124205/231012_HEMPER_NOVEMBER_DONUT_LIFESTYLE_001_2000x2000-1024x1024.jpg" alt="" class="wp-image-856086" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03124205/231012_HEMPER_NOVEMBER_DONUT_LIFESTYLE_001_2000x2000-1024x1024.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03124205/231012_HEMPER_NOVEMBER_DONUT_LIFESTYLE_001_2000x2000-300x300.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03124205/231012_HEMPER_NOVEMBER_DONUT_LIFESTYLE_001_2000x2000-150x150.jpg 150w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03124205/231012_HEMPER_NOVEMBER_DONUT_LIFESTYLE_001_2000x2000-768x768.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03124205/231012_HEMPER_NOVEMBER_DONUT_LIFESTYLE_001_2000x2000.jpg 1080w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
&#8220;Hara Supply is our contract manufacturing side—we make pre-roll cones, combustible products, packaging, and other cannabis industry supply products,&#8221; explains RJ Bhasin, CFO of Hara Supply. &#8220;Hemper focuses on the consumer market, with brands like Goody Glass and Smoke Fiends. We sell to both B2C and B2B customers.&#8221;
While influencer-driven product drops often steal the spotlight, it's contract manufacturing where the real revenue lies—and that side of the business requires just as much strategic marketing.
&#8220;A lot of it revolves around compliance: rules, regulations and testing,&#8221; says Thai Tran, chief creative officer at Hara Supply. &#8220;Different states have different rules, and we have to streamline that communication with our customers, many of whom are MSOs or cannabis brands.&#8221;
Beyond regulations, Hara Supply has built its reputation on transparency and quality control.
&#8220;We provide education on where our paper comes from, how it's produced and ensure ethical manufacturing,&#8221; says Bhasin. &#8220;Many competitors use sweatshops—we don't. We have good manufacturing practices and certifications that set us apart. Transparency is key, especially when working with MSOs. They need to know they can trust our process.&#8221;
Also Read: <a href="https://www.benzinga.com/markets/cannabis/25/01/42962940/this-is-how-you-make-quality-joints-how-one-machine-produces-900-pre-rolls-an-hour-and-why-theyre-better-than-cones">&#8216;This Is How You Make Quality Joints&#8217; &#8211; How One Machine Produces 900 Pre-Rolls An Hour And Why They&#8217;re Better Than Cones</a>
<h2 class="wp-block-heading">Revolutionizing Pre-Roll Manufacturing</h2>
For years, rolling papers from India were met with skepticism.
&#8220;When we first started making cones in India, there was skepticism,&#8221; says Bhasin. &#8220;People assumed they were low quality and made in sweatshops. We had to educate customers that our factories are different: we own them, they are ethical and our products pass any test. We have an open-door policy; anyone can visit our factories in India.&#8221;
That supply chain transparency has become a major selling point.
&#8220;While we haven't seen recalls in the cannabis industry like in food, we believe there should be systems in place to track down to the fiber level,&#8221; says Gerber. &#8220;That's why we use <a href="https://www.benzinga.com/markets/cannabis/23/08/33969516/don-levin-republic-brands-OCB-rolling-papers">Republic Paper</a>—they can track everything from fiber to finished bobbins, and we track from bobbin to cone. It gives MSOs peace of mind.&#8221;
<h2 class="wp-block-heading">Market Growth And Scale: A Billion-Dollar Boom</h2>
The cannabis accessories industry is expanding at an unprecedented rate:
<ul>
<li>The pre-rolled cones market was <a href="https://www.industryresearch.biz/global-pre-rolled-cone-and-conical-tips-market-24226195">valued</a> at $524.18 million in 2022 and is projected to hit $12.55 billion by 2028 with a CAGR of 69.78%.</li>
<li>Hara Supply <a href="https://www.marketresearch.com/Maia-Research-v4212/Global-Pre-Rolled-Cones-Research-37505778/">dominates</a> with a 37.91% market share in the pre-rolled cone sector in 2023.</li>
<li>The global smoking accessories <a href="https://www.grandviewresearch.com/industry-analysis/smoking-accessories-market-report">market</a>—which includes rolling papers, lighters, pipes and vaporizers—was valued at $64.4 billion in 2021 and is projected to reach $91.9 billion by 2030.</li>
</ul>
By focusing on customization, ethical manufacturing practices and supply chain efficiency, Hara Supply continues to lead this rapidly expanding market.
<h2 class="wp-block-heading">The Cone vs. Straight Joint Debate</h2>
While some traditionalists still prefer straight pre-rolls, cones have taken over.
&#8220;There's part of the community that doesn't like the cigarette-style roll,&#8221; says Gerber. &#8220;Cones are easier for filling machines. The tube style is harder to fill with existing filling machines.&#8221;
&#8220;Also, the aerodynamics of the cone makes for a better pull,&#8221; adds Tran. &#8220;And if a straight roll canoes, you're done. With a cone, you can save it and relight the other side.&#8221;
As automation struggles to perfectly pack straight pre-rolls, cones offer a more consistent smoking experience—a trend that Hara Supply is capitalizing on by scaling its glass-tipped, ceramic-tipped and wood-tipped custom cones for brands looking to differentiate their products.
Also Read: <a href="https://www.benzinga.com/markets/cannabis/25/03/44513092/kosher-for-passover-thc-gummies-are-here-a-historic-first-for-jewish-cannabis-lovers">Kosher-For-Passover THC Gummies Are Here: A Historic First For Jewish Cannabis Lovers</a>
<h2 class="wp-block-heading">Expanding Beyond Borders</h2>
The cannabis industry isn't just booming in North America. Global markets are opening up fast, and Hara Supply is leading the charge.
&#8220;We did the InterTabac trade show in Germany and Spannabis in Spain, which helped us break into European markets,&#8221; says Gerber. &#8220;We now distribute in the UK, Spain (through Plantasaur), Poland, South Africa, Thailand, Germany, the Netherlands and France. We're also targeting the coffee shop market.&#8221;
In Europe, the coffee shop model is proving to be a major opportunity.
&#8220;A good coffee shop in Barcelona goes through about 15,000 pre-rolls a week,&#8221; says Bhasin. &#8220;Some of them use between 6 to 10 million cones per year.&#8221;
Germany's experimental cannabis model and Switzerland's ongoing cannabis trials have also created new pockets of demand.
&#8220;The Netherlands is always strong because of the coffee shop model, but now we're seeing real traction in Germany and Switzerland,&#8221; explains Tran. &#8220;Israel is also a solid buyer, and we're starting to see movement in South America.&#8221;
<h2 class="wp-block-heading">Where The Market Is Headed</h2>
Logistics and supply chain precision will be critical as the global pre-roll industry scales.
&#8220;A full shipment can contain anywhere from 5 to 9 million cones, depending on how it&#8217;s packed,&#8221; says Gerber. &#8220;When you're operating at this scale, shipping logistics and production efficiency become critical.&#8221;
The next wave of innovation? Terpene-infused rolling papers, cones and unique packaging solutions.
&#8220;The market is evolving and we're evolving with it,&#8221; says Tran.
With Hara Supply's expansion across North America, Europe and emerging markets, one thing is clear: The companies that master scale, innovation and supply chain precision will dominate the future of cannabis accessories.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/03/44523889/can-cannabis-make-sex-better-new-libido-gummies-promise-to-elevate-pleasure">Can Cannabis Make Sex Better? New &#8216;Libido&#8217; Gummies Promise To Elevate Pleasure</a></li>
</ul>
Photos courtesy of Hemper

Cannabis

Latin America

Eurozone

Exclusives

Interview

Why Cannabis Accessory Brands Are Rushing To Expand Globally

Ratings for Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $77.33, a high estimate of $90.00, and a low estimate of $60.00. Witnessing a positive shift, the current average has risen by 1.9% from the previous average price target of $75.89.
<img src="https://www.benzinga.com/files/images/story/2025/1743703599_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Credo Technology Group. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Positive</td>
<td>$60.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$75.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Quinn Bolton</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Thomas O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$85.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Toshiya Hari</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Tore Svanberg</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Credo Technology Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Credo Technology Group compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Credo Technology Group's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Credo Technology Group's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CRDO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Credo Technology Group analyst ratings.</a>
<h2>Discovering Credo Technology Group: A Closer Look</h2>
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
<h3>Financial Milestones: Credo Technology Group's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Credo Technology Group showcased positive performance, achieving a revenue growth rate of 154.44% as of 31 January, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Credo Technology Group's net margin excels beyond industry benchmarks, reaching 21.75%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Credo Technology Group's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 4.95%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Credo Technology Group's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.32% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Credo Technology Group's debt-to-equity ratio is below the industry average. With a ratio of 0.03, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRDO

A Glimpse Into The Expert Outlook On Credo Technology Group Through 9 Analysts

Analysts' ratings for Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Synchrony Financial and provided 12-month price targets. The average target is $73.55, accompanied by a high estimate of $85.00 and a low estimate of $65.00. Surpassing the previous average price target of $73.06, the current average has increased by 0.67%.
<img src="https://www.benzinga.com/files/images/story/2025/1743703585_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Synchrony Financial's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Donald Fandetti</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$65.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$70.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$77.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Karl Shepard</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$73.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>David Rochester</td>
<td>Compass Point</td>
<td>Announces</td>
<td>Neutral</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Mihir Bhatia</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Eric Wasserstrom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$82.00</td>
<td>$72.50</td>
</tr>
<tr>
<td>Brian Foran</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Hold</td>
<td>$72.00</td>
<td>-</td>
</tr>
<tr>
<td>Mark Devries</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$59.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Synchrony Financial. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Synchrony Financial compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Synchrony Financial's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Synchrony Financial's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SYF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Synchrony Financial analyst ratings.</a>
<h2>Get to Know Synchrony Financial Better</h2>
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
<h3>Unraveling the Financial Story of Synchrony Financial</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Synchrony Financial's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 3.88%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Synchrony Financial's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 19.81% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.0%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.63%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.01.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Synchrony Financial Stock: Analyst Perspectives (11 Ratings)

Throughout the last three months, 18 analysts have evaluated Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">10</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $88.44, a high estimate of $115.00, and a low estimate of $78.00. This current average has decreased by 2.68% from the previous average price target of $90.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1743703384_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Uber Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Andrew Cheng</td>
<td>KGI Securities</td>
<td>Announces</td>
<td>Neutral</td>
<td>$78.00</td>
<td>-</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$92.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$87.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Tom White</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$87.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Ronald Josey</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$92.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$107.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$82.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Uber Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Uber Technologies compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Uber Technologies's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Uber Technologies's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/UBER/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Uber Technologies analyst ratings.</a>
<h2>Discovering Uber Technologies: A Closer Look</h2>
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 171 million users who order rides or food at least once a month.
<h3>Understanding the Numbers: Uber Technologies's Finances</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3 months period, Uber Technologies showcased positive performance, achieving a revenue growth rate of 20.36% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Uber Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 57.55% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 37.88%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Uber Technologies's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 14.0%, the company showcases efficient use of assets and strong financial health.
Debt Management: Uber Technologies's debt-to-equity ratio is below the industry average at 0.52, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

UBER

A Glimpse Into The Expert Outlook On Uber Technologies Through 18 Analysts

VanEck has made a big move in bringing a Binance Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) ETF to the United States. The company recently registered for a BNB ETF trust in the state of Delaware, an important milestone <a href="https://www.benzinga.com/topic/crypto-market">for the crypto asset. </a>​
What This Means for BNB
This action positions Binance Coin with other giant cryptocurrencies—Bitcoin, Ethereum, Solana, and Avalanche—for which <a href="https://www.benzinga.com/etfs">ETF filings </a>have been <a href="https://icis.corp.delaware.gov/eCorp/EntitySearch/NameSearch.aspx">submitted </a>in the country. BNB may have global exchange-traded products (ETPs) such as the 21Shares Binance BNB ETP but has never had one based in the U.S. If approved, VanEck&#8217;s ETF will mirror the price of BNB, offering investors a more convenient means of acquiring exposure to the token.
BNB is trading at around $587.46 at the time of publishing, having lost 2.66% over the past 5 days. Trading volume rose by a massive 42% to over $2.12 billion after VanEck took this step. Being the fifth-largest cryptocurrency on a market cap basis, bringing a spot ETF to the market could legitimize and extend its appeal among retail and institutional investors further.​
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44593556/grayscale-moves-to-mainstream-crypto-with-etf-filings-for-avalanche-top-tokens">Grayscale Moves To Mainstream Crypto With ETF Filings For Avalanche, Top Tokens</a>
A Long Road Ahead
Though this is a major step, it&#8217;s only the first. Registration of a trust in Delaware is a first step prior to making a formal application to the U.S. Securities and Exchange Commission (SEC). VanEck, like other asset managers, has been making efforts to launch new regulated cryptocurrency investment products in the U.S. market. 
The company has already obtained SEC approval for spot Ethereum and Bitcoin ETFs, showing that it can meet the challenging regulatory environment. ​
What&#8217;s Next?
The question now is whether the SEC will be open to a BNB ETF. The regulator has been wary of approving crypto ETFs other than Bitcoin and Ethereum, but with increased interest in Solana and Avalanche ETFs, the winds could be changing. If VanEck manages to win approval, it could pave the way for more diversified crypto investment vehicles in the U.S.​
For now, investors and crypto enthusiasts will be watching closely as VanEck makes its case for the first-ever U.S.-based BNB ETF.
Next Up: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44613351/chipotles-stock-is-sizzling-bill-ackman-loves-it-and-these-etfs-do-too">Chipotle&#8217;s Stock Is Sizzling—Bill Ackman Loves It And These ETFs Do Too</a></li>
</ul>
Photo by Iryna Budanova on Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

New ETFs

ETFs

$BNB

VanEck Moves Closer To US Binance Coin ETF — But Will The SEC Play Ball?

EPR Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPR#NYSE">EPR</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated EPR Props and provided 12-month price targets. The average target is $52.67, accompanied by a high estimate of $58.00 and a low estimate of $50.00. Surpassing the previous average price target of $48.83, the current average has increased by 7.86%.
<img src="https://www.benzinga.com/files/images/story/2025/1743703304_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive EPR Props. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$53.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Ki Bin Kim</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$51.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>John Kilichowski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$52.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$58.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$52.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to EPR Props. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of EPR Props compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of EPR Props's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of EPR Props's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EPR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EPR Props analyst ratings.</a>
<h2>About EPR Props</h2>
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.
<h3>Unraveling the Financial Story of EPR Props</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: EPR Props displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 2.58%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: EPR Props's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -8.8%, the company may face hurdles in effective cost management.
Return on Equity (ROE): EPR Props's ROE stands out, surpassing industry averages. With an impressive ROE of -0.61%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): EPR Props's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.26%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.32, EPR Props adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About EPR Props Stock

NTSB Says Issues A Total Of Seven Safety Recommendations To The FAA And Boeing To Address Noncompliant Evacuation Slide Components On Boeing Airplanes

First Citizens BancShares's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NYSE">FCNCA</a>) short percent of float has risen 9.87% since its last report. The company recently reported that it has 323 thousand shares sold short, which is 3.34% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.31 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>First Citizens BancShares Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743703259_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for First Citizens BancShares has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing First Citizens BancShares's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, First Citizens BancShares's peer group average for short interest as a percentage of float is 1.13%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

FCNCA

Looking Into First Citizens BancShares's Recent Short Interest

New Fortress Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NYSE">NFE</a>) short percent of float has risen 22.73% since its last report. The company recently reported that it has 38.83 million shares sold short, which is 26.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.75 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>New Fortress Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743703253_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for New Fortress Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing New Fortress Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, New Fortress Energy's peer group average for short interest as a percentage of float is 3.44%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is New Fortress Energy Gaining or Losing Market Support?

In the preceding three months, 10 analysts have released ratings for Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Agree Realty, revealing an average target of $78.6, a high estimate of $84.00, and a low estimate of $74.00. Observing a 0.7% increase, the current average has risen from the previous average price target of $78.05. 
<img src="https://www.benzinga.com/files/images/story/2025/1743703251_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Agree Realty's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>John Kilichowski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$75.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$78.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$74.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$79.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$74.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.50</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$79.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$79.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Agree Realty. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Agree Realty compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Agree Realty's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ADC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Agree Realty analyst ratings.</a>
<h2>Discovering Agree Realty: A Closer Look</h2>
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
<h3>A Deep Dive into Agree Realty's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Agree Realty's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.49% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Real Estate sector.
Net Margin: Agree Realty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 26.92% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Agree Realty's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.83%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Agree Realty's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.52%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Agree Realty's debt-to-equity ratio is below the industry average. With a ratio of 0.53, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Agree Realty: Insights From 10 Analyst Reviews

Apple's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NYSE">AAPL</a>) short percent of float has fallen 4.44% since its last report. The company recently reported that it has 129.68 million shares sold short, which is 0.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Apple Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743703247_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Apple has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Apple's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Apple's peer group average for short interest as a percentage of float is 8.98%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AAPL

What Does the Market Think About Apple?

In the current market session, Ovintiv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) share price is at $40.84, after a 7.48% drop. Over the past month, the stock increased by 4.79%, but over the past year, it actually fell by 27.97%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1743703226_0.png" alt="Past Year Chart" />

<h3>Comparing Ovintiv P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Ovintiv has a lower P/E than the aggregate P/E of 30.02 of the Oil, Gas &amp; Consumable Fuels industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743703226_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Ovintiv Inc's Price Over Earnings

In the last three months, 8 analysts have published ratings on Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Altimmune, revealing an average target of $16.0, a high estimate of $25.00, and a low estimate of $12.00. Observing a 1.85% increase, the current average has risen from the previous average price target of $15.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1743703213_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A clear picture of Altimmune's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Jonathan Wolleben</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Jonathan Wolleben</td>
<td>Citizens Capital Markets</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Annabel Samimy</td>
<td>Stifel</td>
<td>Announces</td>
<td>Buy</td>
<td>$18.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Altimmune. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Altimmune compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Altimmune's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ALT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Altimmune analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Altimmune</h2>
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
<h3>Financial Milestones: Altimmune's Journey</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Negative Revenue Trend: Examining Altimmune's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -86.49% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Altimmune's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -463600.0%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Altimmune's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -18.05%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Altimmune's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -16.14%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

8 Analysts Assess Altimmune: What You Need To Know

WIIM

ABTS

ADBE

ADSK

ALKT

ASAN

AUID

AVPT

BILL

BRZE

BTBT

BTDR

BTOG

CFLT

CIFR

CRWD

CVLT

CYBR

DDOG

DOCU

ESTC

FROG

FRSH

FTNT

GTLB

HUBS

INTA

INTU

KVYO

NCNO

ORCL

PANW

PATH

PEGA

QTWO

QUBT

RBRK

SEMR

SOUN

WDAY

Shares of software companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Goldman Sachs analyst Susan Maklari maintains Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) with a Sell and raises the price target from $39 to $44.

Goldman Sachs Maintains Sell on Worthington Enterprises, Raises Price Target to $44

Decentralized exchange aggregator ParaSwap has rebranded to Velora, unveiling a major technical shift toward intents-based trading—a model that departs from traditional single-block execution by allowing traders to express desired outcomes rather than fixed transaction paths.
The shift, announced Thursday, is built on the release of Velora's Delta v2.5 infrastructure, introducing a competitive agent model where solvers and market makers vie to fulfill user-defined trading goals. 
This marks a move away from the legacy aggregator model that has underpinned decentralized finance since its early growth.
At its core, intents-based trading enables users to specify conditions or outcomes—such as a desired price or action—without defining every technical step of the trade. 
Competing agents then optimize execution within those parameters. 
This opens up use cases like on-chain limit orders and cross-chain swaps, previously constrained by smart contract rigidity and single-block processing limitations.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44630530/bondex-web3-app-surpasses-5m-downloads-amid-growing-interest-in-decentralized-career-platforms">Bondex Web3 App Surpasses 5M Downloads Amid Growing Interest In Decentralized Career Platforms</a>
"Legacy aggregators are limited by rigid smart contracts and same-chain execution," said Velora founder Mounir Benchemled. "Intents offer greater flexibility, giving users more control over how and when their trades are executed."
According to a press release, Velora also introduces features like Instant Cross-Chain Swaps—which aim to eliminate delays and reduce bridging risks—and a Super Hooks system, allowing users to automate complex trading workflows, such as collateral swaps or liquidity pool management.
Another feature is chain abstraction, which allows users to initiate and complete trades across multiple blockchains without manual bridging. 
This is central to Velora's approach to improving speed, flexibility, and overall efficiency in decentralized markets.
While the concept of intents-based DEXs has gained attention across DeFi, practical implementations have lagged. 
Velora positions its infrastructure as a more production-ready version, built for both performance and usability. 
The system is modular, allowing for future upgrades and the inclusion of new agent types as on-chain liquidity and trade complexity grow.
ParaSwap, now Velora, has processed over $100 billion in trading volume since its founding in 2019, and serves more than 4 million wallets, the release further stated.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44628685/bitcoin-is-a-realistic-global-reserve-asset-experts-say">Bitcoin Is A Realistic Global Reserve Asset, Experts Say</a></li>
</ul>
Image: Shutterstock

Velora Rebrand Introduces Intents-Based Trading To Enhance DeFi Execution

Goldman Sachs analyst Alexander Blostein maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Buy and lowers the price target from $70 to $63.

Goldman Sachs Maintains Buy on TPG, Lowers Price Target to $63

Press Releases

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Offerings

WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth

Physicians' Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer

Case Study: bioAffinity Technologies' Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence

Case Study: bioAffinity Technologies' CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside

Comments

bioAffinity Technologies

Intérêt court

bioAffinity Technologies (NASDAQ:BIAF) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL